Risk of Suicidal Events in Youths Taking Atomoxetine Compared with Those on Methylphenidate; An Observational Cross-Sectional Study

• Ngā kaituhi matua: Padideh Ghaeli (Author), Javad Mahmoudi-Gharaei (Author), Leila Kouti (Author), Alia Shakiba (Author), Reza Hazara (Author), Abbas Alimadadi (Author)
• Hōputu: Pukapuka
• I whakaputaina: Research Center for Rational Use of Drugs (RCRUD), 2021-12-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Background: Stimulants such as methylphenidate and atomoxetine, a nonstimulant norepinephrine reuptake inhibitor, are approved for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Associations between the use of methylphenidate or atomoxetine with suicidal ideation and suicide-relat...